Pathological cardiac remodeling seen by the eyes of proteomics
- PMID: 33607275
- DOI: 10.1016/j.bbapap.2021.140622
Pathological cardiac remodeling seen by the eyes of proteomics
Abstract
Cardiac remodeling involves cellular and structural changes that occur as consequence of multifactorial events to maintain the homeostasis. The progression of pathological cardiac remodeling involves a transition from adaptive to maladaptive changes that eventually leads to impairment of ventricular function and heart failure. In this scenario, proteins are key elements that orchestrate molecular events as increased expression of fetal genes, neurohormonal and second messengers' activation, contractile dysfunction, rearrangement of the extracellular matrix and alterations in heart geometry. Mass spectrometry based-proteomics has emerged as a sound method to study protein dysregulation and identification of cardiac diseases biomarkers in plasma. In this review, we summarize the main findings related to large-scale proteome modulation of cardiac cells and extracellular matrix occurred during pathological cardiac remodeling. We describe the recent proteomic progresses in the selection of protein targets and introduce the renin-angiotensin system as an interesting target for the treatment of pathological cardiac remodeling.
Keywords: Cardiac hypertrophy; Cardiac remodeling, extracellular matrix; Cardiovascular diseases; Heart failure; Mass spectrometry, proteome; Myocardial infarction.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Autophagy during cardiac remodeling.J Mol Cell Cardiol. 2016 Jun;95:11-8. doi: 10.1016/j.yjmcc.2015.12.003. Epub 2015 Dec 8. J Mol Cell Cardiol. 2016. PMID: 26678624 Review.
-
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20. Circ Res. 2019. PMID: 31219741 Free PMC article. Review.
-
Subcellular remodeling as a viable target for the treatment of congestive heart failure.J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):31-45. doi: 10.1177/107424840601100103. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703218 Review.
-
Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.J Muscle Res Cell Motil. 2015 Dec;36(6):447-61. doi: 10.1007/s10974-015-9434-0. Epub 2015 Dec 14. J Muscle Res Cell Motil. 2015. PMID: 26668058 Free PMC article.
-
Proteomic analysis of short-term preload-induced eccentric cardiac hypertrophy.J Transl Med. 2016 May 27;14(1):149. doi: 10.1186/s12967-016-0898-5. J Transl Med. 2016. PMID: 27234427 Free PMC article.
Cited by
-
Effects of Resistance Exercise on Slow-Twitch Soleus Muscle of Infarcted Rats.Antioxidants (Basel). 2023 Jan 27;12(2):291. doi: 10.3390/antiox12020291. Antioxidants (Basel). 2023. PMID: 36829850 Free PMC article.
-
FUNDC1: An Emerging Mitochondrial and MAMs Protein for Mitochondrial Quality Control in Heart Diseases.Int J Mol Sci. 2023 May 23;24(11):9151. doi: 10.3390/ijms24119151. Int J Mol Sci. 2023. PMID: 37298100 Free PMC article. Review.
-
Bioinformatic Analysis of the Subproteomic Profile of Cardiomyopathic Tissue.Methods Mol Biol. 2023;2596:377-395. doi: 10.1007/978-1-0716-2831-7_26. Methods Mol Biol. 2023. PMID: 36378452
-
Plasma Proteomic Patterns Show Sex Differences in Early Concentric Left Ventricular Remodeling.Circ Heart Fail. 2023 Jul;16(7):e010255. doi: 10.1161/CIRCHEARTFAILURE.122.010255. Epub 2023 Jun 29. Circ Heart Fail. 2023. PMID: 37381923 Free PMC article.
-
Cardioproteomics: Insights on Cardiovascular Diseases.Adv Exp Med Biol. 2024;1443:159-171. doi: 10.1007/978-3-031-50624-6_8. Adv Exp Med Biol. 2024. PMID: 38409420 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources